To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Internet: Outages
Monday 1st December 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what estimate her Department has made of the cost to the economy of recent outages of large-scale cloud providers.

Answered by James Murray - Chief Secretary to the Treasury

I refer the member to the answer given to UIN 92928 on 24 November 2025.


Written Question
Drugs: VAT
Tuesday 11th November 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, whether she has made an assessment of the potential impact of introducing VAT to to medicines provided free under Early Access Medicines Scheme programmes on pharmaceutical companies.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

I refer the honourable member to the answer that I gave to PQ UIN: 87051.


Written Question
Drugs: VAT
Wednesday 5th November 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what assessment her (a) Department and (b) HMRC have conducted on the potential impact on clinical trial numbers from the introduction of VAT to medicines provided free under Early Access Medicines Scheme programmes.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services.

Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval.

Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair. Whether VAT applies to medicines or treatments provided for free under the EAMS will depend on the precise facts of the case. In certain circumstances the giving of goods away for free can be outside the scope of VAT. Where the supply is within the scope of VAT a relief may apply, meaning the supply can be made VAT free.


Written Question
Drugs: VAT
Wednesday 5th November 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what assessment (a) her Department and (b) HMRC have conducted on the potential impact on patient access to innovative medicines from the introduction of VAT to medicines provided free under Early Access Medicines Scheme programmes.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services.

Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval.

Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair. Whether VAT applies to medicines or treatments provided for free under the EAMS will depend on the precise facts of the case. In certain circumstances the giving of goods away for free can be outside the scope of VAT. Where the supply is within the scope of VAT a relief may apply, meaning the supply can be made VAT free.


Written Question
Business: Investment
Tuesday 4th November 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what assessment her Department has made of the potential merits of reforming the (a) Enterprise Investment Scheme and (b) Seed Enterprise Investment Scheme to improve support for firms in the post-start-up phase.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

The Government is focused on making the UK the best place in the world to start and grow a business, and understands the key role of a competitive investment environment in achieving economic growth.

At Autumn Budget 2024, the Government committed to creating a positive environment for entrepreneurship and business investment. We are working with leading entrepreneurs and venture capital firms on how policy supports that, including the role of the Enterprise Investment Scheme and Seed Enterprise Investment Scheme.


Written Question
Business: Investment
Tuesday 4th November 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, whether she plans to expand the (a) Enterprise Investment Scheme and (b) Seed Enterprise Investment Scheme scheme to support older companies seeking increased investment.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

The Government is focused on making the UK the best place in the world to start and grow a business, and understands the key role of a competitive investment environment in achieving economic growth.

At Autumn Budget 2024, the Government committed to creating a positive environment for entrepreneurship and business investment. We are working with leading entrepreneurs and venture capital firms on how policy supports that, including the role of the Enterprise Investment Scheme and Seed Enterprise Investment Scheme.


Written Question
Drugs: VAT
Wednesday 29th October 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, if she will take steps with HM Revenue and Customs to help ensure that a(a) medicines and (b) treatments provided under the Early Access to Medicines Scheme are not subjected to (i) direct or (ii) indirect VAT.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

VAT is the UK’s second largest tax, forecast to raise £180 billion in 2025/26. Taxation is a vital source of revenue which helps to fund public services.

Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval.

Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair. If a business has reclaimed VAT on costs (like making or importing goods), it should not avoid accounting VAT when those goods leave the business for free.

Whether VAT applies to medicines or treatments provided for free under the EAMS will depend on the precise facts of the case. In certain circumstances the giving of goods away for free can be outside the scope of VAT. Where the supply is within the scope of VAT a relief may apply, meaning the supply can be made VAT free.

The Government keeps all taxes under review but there are no plans to change the law for Deemed Supplies.


Written Question
Drugs: VAT
Wednesday 29th October 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, if she will commission guidance from HM Revenue and Customs clarifying whether medicines supplied under the Early Access Medicines Scheme fall outside the scope of VAT Deemed Supply rules.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies.

This is to keep the system fair if a business has reclaimed VAT on costs (like making or importing goods), it should not avoid accounting for VAT when those goods leave the business for free.

Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval. Whether VAT applies to medicines or treatments provided for free under the EAMS will depend on the precise facts of the case. Where the supply of free medicine under the EAMS meets the criteria of a deemed supply, VAT will be due.

HMRC considers that the guidance around these rules is clear and long-established.


Written Question
Drugs: VAT
Wednesday 29th October 2025

Asked by: Julia Lopez (Conservative - Hornchurch and Upminster)

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, whether medicines provided free under Early Access Medicines Scheme programmes are liable for output VAT.

Answered by Dan Tomlinson - Exchequer Secretary (HM Treasury)

Early Access to Medicines Scheme (EAMS) allows patients access to free medicines for life threatening conditions before receiving full NHS approval.

There are special VAT rules for the supply of goods without payment. Whether VAT applies will depend on the precise facts of the case. In certain circumstances the giving of goods away for free can be outside the scope of VAT. Where the supply is within the scope of VAT a relief may apply, meaning the supply can be made VAT free.


Speech in Commons Chamber - Wed 17 Mar 2021
Leaving the EU: Impact on the UK

"I thank all hon. and right hon. Members who have taken part in this afternoon’s debate. The contributions from most have been passionate, insightful and optimistic about our nation’s new path outside the European Union, while recognising that our ambitious and wide-reaching trade and co-operation agreement with the EU will …..."
Julia Lopez - View Speech

View all Julia Lopez (Con - Hornchurch and Upminster) contributions to the debate on: Leaving the EU: Impact on the UK